Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 549-555

  Humbert, M ^a,b,c   Sitbon, O ^a,b,c   Yaici A ^a,b,c   Montani, D ^a,b,c   O'Callaghan, D S ^a,b,c   Jais X ^a,b,c   Parent, F ^a,b,c   Savale, L ^a,b,c   Natali, D ^a,b,c   Gunther S ^a,b,c   Chaouat, A ^d,e   Chabot, F ^e   Cordier, J F ^f   Habib, G ^g   Gressin, V ^h   Jing, Z C ^a,b,c,i   Souza, R ^a,b,c,j   Simonneau, G ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e CHU NANCY BRABOIS   (France)

^f LOUIS PRADEL HOSPITAL   (France)

^g TIMONE HOSPITAL   (France)

^h Actelion Pharmaceuticals France   (France)

ⁱ TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

Exercise; Mortality; Pulmonary arterial hypertension; Risk factors; Sex

Indexed keywords

ANOREXIGENIC AGENT;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXERCISE; FAMILIAL DISEASE; FATALITY; FEMALE; HEART OUTPUT; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

AGED; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PULMONARY MEDICINE; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955953602     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00057010     Document Type: Article

References (28)

1. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006; 114: 1417-1431.
2. Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
3. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 13S-24S.
4. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004; 351: 1655-1665.
5. Simonneau G, Robbins I, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S43-S54.
6. Sztrymf B, Coulet F, Girerd B, et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 2008; 177: 1377-1383.
7. Girerd B, Montani D, Coulet F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 2010; 181: 851-861.
8. Souza R, Humbert M, Sztrymf B, et al. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases. Eur Respir J 2008; 31: 343-348.
9. Dimopoulos K, Inuzuka R, Goletto S, et al. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010; 121: 20-25.
10. Le Pavec J, Humbert M, Mouthon L, et al. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 181: 1285-1293.
11. Le Pavec J, Souza R, Herve P, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med 2008; 178: 637-643.
12. Degano B, Guillaume M, Savale L, et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010; 24: 67-75.
13. Fernandes CJCS, Jardim C, Hovnanian A, et al. Survival in schistosomiasis associated pulmonary arterial hypertension. J Am Coll Cardiol 2010; [Epub ahead of print DOI: 10.1016/j.jacc.2010.03.065].
14. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk of death in patients with sickle cell disease. N Engl J Med 2004; 350: 886-895. (Pubitemid 38252536)
15. Rich S, Danzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Int Med 1987; 107: 216-223. (Pubitemid 17137857)
16. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Ann Int Med 1991; 115: 343-349.
17. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002; 106: 1477-1782.
18. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788. (Pubitemid 34925627)
19. Hoeper MM, Gall H, Seyfarth HJ, et al. Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J 2009; 34: 132-137.
20. McLaughlin VV, Sitbon O, Badesch DB, et al. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005; 25: 244-249. (Pubitemid 40246523)
21. Barst RJ, Galie N, Naeije R, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J 2006; 28: 1195-1203. (Pubitemid 44883856)
22. Thenappan T, Shah SJ, Rich S, et al. Contemporary survival in patients with pulmonary arterial hypertension: a reappraisal of the National Institutes of Health Risk Stratification Equation. Eur Respir J 2010; 35: 1079-1089.
23. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010; 122: 156-163.
24. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030.
25. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425-1436.
26. Sitbon O, Humbert M, Simonneau G. Treatment for pulmonary arterial hypertension under the new French hospital financing system: recommendations of the Pulmonary Vascular Diseases Working Group of the French Society of Pulmonary Medicine. Presse Med 2005; 34: 1456-1464. (Pubitemid 41617558)
27. Galiè N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009; 30: 394-403.
28. Austin ED, Cogan JD, West JD, et al. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009; 34: 1093-1099.